The letter by Kirch and colleagues has raised questions about the statistical procedures used in our analysis of haloperidol levels and clinical response.1 We believe that some of the points Kirch et al raise may not be valid; other legitimate concerns they raise have been addressed in a subsequent report from our group.2First, Kirch et al question the use of the linear regression procedure to estimate improvement in psychopathology scores. The rationale and justification for our statistical procedures and the use of linear regression have been presented in greater detail in our subsequent article,2 which analyzed a slightly enlarged sample. Briefly, linear regressions were fitted to the patients' BPRS psychosis factor scores because scatter plots of these psychopathology scores by the day of treatment did not support the assumption of curvilinear trends for their response to haloperidol during the first 31/2 weeks of drug treatment. Only one of 34 patients of
Smith RC. The Interpretation of Plasma Haloperidol Concentrations-Reply. Arch Gen Psychiatry. 1985;42(8):839–840. doi:https://doi.org/10.1001/archpsyc.1985.01790310107017
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: